- Compensation of the Management Board
- Commitments to members of the Management Board for the event of the termination of their appointment
- Miscellaneous
- Adjustments to to system of compensation of the Management Board
- Information on the supervisory board
Information on the supervisory board
The compensation of the Supervisory Board is determined by the Annual General Meeting and is subject to the provisions contained in Section 14 of the Company statutes of Fresenius SE. Each member of the Supervisory Board shall receive a fixed compensation of € 13 thousand. The members of the Audit Committee and the Personnel Committee of the Supervisory Board receive an additional € 10 thousand each and the Chairman of the committee a further € 10 thousand. For each full fiscal year, the remuneration increases by 10 % for each percentage point that the dividend paid on each ordinary share for that year (gross dividend according to the resolution of the Annual General Meeting) exceeds 3.6 % of the amount equal to the subscribed capital divided by the number of non-par value shares; residual amounts are interpolated. The Chairman receives twice this amount and the deputies to the Chairman one and a half times the amount of a Supervisory Board member. All members of the Supervisory Board receive appropriate compensation for costs of travel and accommodation incurred in connection with their duties as members of the Supervisory Board. Fresenius SE provides to the members of the Supervisory Board insurance coverage in an adequate amount (relating to their function) and on an adequate excess amount basis.
For the years 2009 and 2008, the compensation for the members of the Supervisory Board of Fresenius SE, including compensation for committee services, was as follows:
| Fixed compensation | Compensation for committee services |
Variable compensation |
Total compensation |
|||||
|---|---|---|---|---|---|---|---|---|
| in thousand € | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 | 2009 | 2008 |
| Dr. Gerd Krick | 26 | 26 | 30 | 30 | 186 | 173 | 242 | 229 |
| Dr. Dieter Schenk | 20 | 20 | 0 | 0 | 139 | 129 | 159 | 149 |
| Niko Stumpfögger | 20 | 20 | 0 | 0 | 139 | 129 | 159 | 149 |
| Prof. Dr. h. c. Roland Berger (since May 21, 2008) |
13 | 8 | 20 | 12 | 93 | 53 | 126 | 73 |
| Dario Ilossi | 13 | 13 | 0 | 0 | 93 | 86 | 106 | 99 |
| Konrad Kölbl | 13 | 13 | 10 | 10 | 93 | 86 | 116 | 109 |
| Dr. Gabriele Kröner (until May 21, 2008) |
0 | 5 | 0 | 0 | 0 | 33 | 0 | 38 |
| Klaus-Peter Müller (since May 21, 2008) |
13 | 8 | 0 | 0 | 93 | 53 | 106 | 61 |
| Dr. Gerhard Rupprecht | 13 | 13 | 0 | 0 | 93 | 86 | 106 | 99 |
| Wilhelm Sachs | 13 | 13 | 10 | 10 | 93 | 86 | 116 | 109 |
| Dr. Karl Schneider | 13 | 13 | 20 | 20 | 93 | 86 | 126 | 119 |
| Stefan Schubert | 13 | 13 | 0 | 0 | 93 | 86 | 106 | 99 |
| Rainer Stein | 13 | 13 | 10 | 10 | 93 | 86 | 116 | 109 |
| Dr. Bernhard Wunderlin (until May 21, 2008) |
0 | 5 | 0 | 8 | 0 | 33 | 0 | 46 |
| Total | 183 | 183 | 100 | 100 | 1,301 | 1,205 | 1,584 | 1,488 |
Corporate governance
